Fetal Monitoring Market by Product {Ultrasound (2D, 3D & 4D, and Doppler Imaging), Intrauterine Pressure Catheter (IUPC), Telemetry Solutions, Electronic Fetal Monitoring (EFM) (External & Internal), Fetal Electrodes, Fetal Doppler, Accessories & Consumables, and Other Products}, Method (Invasive and Non-Invasive), Portability (Portable and Non-Portable), Application (Intrapartum Fetal Monitoring and Antepartum Fetal Monitoring): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4162605
- 214 Pages
- November 2020
- Pharmaceuticals
Fetal monitoring is vital diagnostic tool used to monitor movement and heart rate of a fetus and maternal contractions. It is a fundamental device used for monitoring uterine contractions during labor. It mainly monitors well-being of fetus and progress of labor. In medical terms, it is referred as medical method to check health of an unborn baby to ensure a safe birth. In addition, it is also used to monitor chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision & hearing problems, jaundice, and neonatal diseases.
Increase in preterm births & birth rates, rise in technological advancements, increase in need for fetal monitoring during pregnancy, rise in antepartum hemorrhage rate, and premature delivery rate drive the global fetal monitoring market. However, high cost of equipment, stringent regulatory procedures, and low prevalence of birth rates, especially in few developed countries impede the market growth. Further, emerging technologies, such as portable & wireless products and untapped emerging economies offer lucrative opportunities for the market players.
The global fetal monitoring market is segmented on the basis of product, method, portability, application, and geography. By product, it is divided into ultrasound, intrauterine pressure catheter (IUPC), telemetry solutions, electronic fetal monitoring (EFM), fetal electrodes, fetal doppler, accessories, consumables, and other products.
The ultrasound product segment held the largest market share in 2019, owing to technological advancements and a wide array of applications. By method, the market is bifurcated into non-invasive and invasive fetal monitoring methods. The non-invasive method held the highest market share in 2019, owing to advancements in fetal monitoring methods. By application, it is categorized into antepartum fetal monitoring and intrapartum fetal monitoring applications. The antepartum fetal monitoring application was the highest revenue contributor in 2019, while the intrapartum fetal monitoring segment is anticipated to grow at the highest rate. Growth of the intrapartum application segment is high as these applications are mostly carried out during second and third trimesters of pregnancy. This application also reduces the incidences of stillbirths by routinely assessing the risk of fetal death in complicated pregnancies with preexisting maternal conditions such as diabetes mellitus.
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to factors such as well-equipped and better financed hospitals & clinics, high adoption rate for technologically advanced products, and sophisticated healthcare infrastructure. Moreover, the U.S. is the target area for top players in the market, owing to high awareness about fetal monitoring. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.
The key players operating in the global fetal monitoring market include GE Healthcare, Analogic Corporation, Fujifilm Sonosite, Inc., Koninklijke Philips N.V., Siemens Healthcare, Medtronic Plc, Getinge Group, Neoventa Medical AB, Natus Medical Incorporated, and OSI Systems, Inc.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
• A comprehensive analysis of the countries in North America, Europe, Asia-Pacific, and LAMEA is provided to determine the existing opportunities.
• The key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
• Ultrasound
o 2D Ultrasound
o 3D & 4D Ultrasound
o Doppler Imaging
• Intrauterine Pressure Catheter (IUPC)
• Telemetry Solutions
• Electronic Fetal Monitoring (EFM)
o External EFM
o Internal EFM
• Fetal Electrodes
• Fetal Doppler
• Accessories & Consumables
• Other Products
By Method
• Invasive
• Non-Invasive
By Portability
• Portable
• Non-Portability
By Application
• Intrapartum Fetal Monitoring
• Antepartum Fetal Monitoring
By End User
• Hospitals
• Clinics
• Others
By Region
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific
• Japan
• China
• India
• Australia
• Rest of Asia-Pacific
LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Turkey
• Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• GE Healthcare
• Analogic Corporation
• Fujifilm Sonosite, Inc.
• Koninklijke Philips N.V.
• Siemens Healthcare
• Medtronic Plc
• Getinge Group
• Neoventa Medical AB
• Natus Medical Incorporated
• OSI Systems, Inc.
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Top player positioning
3.2.1.Top investment pockets
3.3.Key forces shaping fetal monitoring industry/market
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in preterm births
3.4.1.2.Perpetual need for fetal monitoring
3.4.1.3.Active government and non-government initiatives
3.4.1.4.Technological advancements
3.4.2.Restraints
3.4.2.1.Stringent regulatory procedures
3.4.2.2.High cost associated with fetal monitoring devices
3.4.2.3.Prevalence of declining birth rates
3.4.3.Opportunity
3.4.3.1.Lucrative opportunities in developing countries
3.4.3.2.Portable and wireless products
3.4.4.Impact Analysis
3.1.Impact analysis of COVID-19 on the fetal monitoring market
3.1.1.Overview
3.1.2.Impact of COVID-19 on fetal monitoring market
CHAPTER 4:FETAL MONITORING MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Ultrasound
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Ultrasound, By type
4.2.2.1.Market size and forecast
4.2.2.2.2D Ultrasound
4.2.2.2.1.Market size and forecast
4.2.2.3.3D & 4D Ultrasound
4.2.2.3.1.Market size and forecast
4.2.2.4.Doppler Imaging
4.2.2.4.1.Market size and forecast
4.3.INTRAUTERINE PRESSURE CATHETER (IUPC)
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.4.TELEMETRY SOLUTIONS
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.5.ELECTRONIC FETAL MONITORING (EFM)
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.2.1.Market size and forecast
4.5.2.2.External EFM
4.5.2.2.1.Market size and forecast
4.5.2.3.Internal EFM
4.5.2.3.1.Market size and forecast
4.6.FETAL ELECTRODES
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.7.FETAL DOPPLER
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.8.ACCESORIES AND CONSUMABLES
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.9.OTHER FETAL MONITORING DEVICES
4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast, by region
CHAPTER 5:FETAL MONITORING MARKET, BY PORTABILITY
5.1.Overview
5.1.1.Market size and forecast
5.2.Non-Portable
5.2.1.Market size and forecast
5.3.Portable
5.3.1.Market size and forecast
CHAPTER 6:FETAL MONITORING MARKET, BY METHOD
6.1.Overview
6.1.1.Market size and forecast
6.2.Non-Invasive Method
6.2.1.Market size and forecast
6.3.Invasive Method
6.3.1.Market size and forecast
CHAPTER 7:FETAL MONITORING MARKET, BY APPLICATION
7.1.Overview
7.1.1.Market size and forecast
7.2.Antepartum Fetal Monitoring
7.2.1.Market size and forecast
7.3.Intrapartum Fetal Monitoring
7.3.1.Market size and forecast
CHAPTER 8:FETAL MONITORING MARKET, BY END USER
8.1.Overview
8.1.1.Market size and forecast
8.2.Hospitals
8.2.1.Market size and forecast
8.3.Clinics
8.3.1.Market size and forecast
8.4.Others
8.4.1.Market size and forecast
CHAPTER 9:FETAL MONITORING MARKET, BY REGION
9.1.Overview
Market size and forecast
9.2.North America
9.2.1.Key market trends, growth factors, and opportunities
9.2.2.Market size and forecast, by country
9.2.3.Market size and forecast, by product
9.2.4.Market size and forecast, by portability
9.2.5.Market size and forecast, by method
9.2.6.Market size and forecast, by application
9.2.7.Market size and forecast, by end user
9.2.7.1.U.S. Market size and Forecast
9.2.7.2.Canada market size and forecast
9.2.7.3.Mexico
9.3.Europe
9.3.1.Key market trends, growth factors, and opportunities
9.3.2.Market size and forecast, by country
9.3.3.Market size and forecast, by product
9.3.4.Market size and forecast, by portability
9.3.5.Market size and forecast, by method
9.3.6.Market size and forecast, by application
9.3.7.Market size and forecast, by end user
9.3.7.1.Germany market size and forecast
9.3.7.2.France market size and forecast
9.3.7.3.UK, market size and forecast
9.3.7.4.Italy market size and forecast
9.3.7.5.Spain market size and forecast
9.3.7.6.Rest of Europe market size and forecast
9.4.Asia-Pacific
9.4.1.Key market trends, growth factors, and opportunities
9.4.2.Market size and forecast, by country
9.4.3.Market size and forecast, by product
9.4.4.Market size and forecast, by portability
9.4.5.Market size and forecast, by method
9.4.6.Market size and forecast, by application
9.4.7.Market size and forecast, by end user
9.4.7.1.Japan market size and forecast
9.4.7.2.China market size and forecast
9.4.7.3.India, market size and forecast
9.4.7.4.Australia market size and forecast
9.4.7.5.Rest of Asia-Pacific, market size and forecast
9.5.LAMEA
9.5.1.Key market trends, growth factors, and opportunities
9.5.2.Market size and forecast, by country
9.5.3.Market size and forecast, by product
9.5.4.Market size and forecast, by portability
9.5.5.Market size and forecast, by method
9.5.6.Market size and forecast, by application
9.5.7.Market size and forecast, by end user
9.5.7.1.Brazil
9.5.7.2.South Africa market size and forecast
9.5.7.3.Saudi Arabia
9.5.7.4.Turkey
9.5.7.5.Rest of LAMEA
CHAPTER 10:COMPANY PROFILES
10.1.Analogic Corporation
10.1.1.Company overview
10.1.2.Company snapshot
10.1.3.Operating business segments
10.1.4.Product portfolio
10.1.5.Business performance
10.2.Cardinal Health
10.2.1.Company overview
10.2.2.Company snapshot
10.2.3.Operating business segments
10.2.4.Product portfolio
10.2.5.Business performance
10.3.FUJIFILM Holdings Corporation
10.3.1.Company overview
10.3.2.Company snapshot
10.3.3.Operating business segments
10.3.4.Product portfolio
10.3.5.Business performance
10.4.GENERAL ELECTRIC
10.4.1.Company overview
10.4.2.Company snapshot
10.4.3.Operating business segments
10.4.4.Product portfolio
10.4.5.Business performance
10.4.6.Key strategic moves and developments
10.5.Getinge AB
10.5.1.Company overview
10.5.2.Company snapshot
10.5.3.Operating business segments
10.5.4.Product portfolio
10.5.5.Business performance
10.6.Koninklijke Philips N.V. (Philips Healthcare)
10.6.1.Company overview
10.6.2.Company snapshot
10.6.3.Operating business segments
10.6.4.Product portfolio
10.6.5.Business performance
10.6.6.Key strategic moves and developments
10.7.Natus Medical Incorporated
10.7.1.Company overview
10.7.2.Company snapshot
10.7.3.Operating business segments
10.7.4.Product portfolio
10.7.5.Business performance
10.8.Neoventa Medical AB
10.8.1.Company overview
10.8.2.Company snapshot
10.8.3.Operating business segments
10.8.4.Product portfolio
10.8.5.Key strategic moves and developments
10.9.OSI Systems, Inc.
10.9.1.Company overview
10.9.2.Company snapshot
10.9.3.Operating business segments
10.9.4.Product portfolio
10.9.5.Business performance
10.10.SIEMENS AG (Siemens Healthineers)
10.10.1.Company overview
10.10.2.Company snapshot
10.10.3.Operating business segments
10.10.4.Product portfolio
10.10.5.Business performance
TABLE 01.GLOBAL FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 02.ULTRASOUND MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.FETAL MONITORING MARKET FOR INTRAUTERINE PRESSURE CATHETER (IUPC), BY REGION, 2019–2027 ($MILLION)
TABLE 04.FETAL MONITORING MARKET FOR TELEMETRY SOLUTIONS, BY REGION, 2019–2027 ($MILLION)
TABLE 05.ELECTRONIC FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 06.ELECTRONIC FETAL MONITORING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.FETAL MONITORING MARKET FOR FETAL ELECTRODE, BY REGION, 2019–2027 ($MILLION)
TABLE 08.FETAL DOPPLER MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.ACCESSORIES AND CONSUMABLES MARKET FOR OBTURATOR, BY REGION, 2019–2027 ($MILLION)
TABLE 10.FETAL MONITORING MARKET FOR OTHER FETAL MONITORING DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 11.FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 12.FETAL MONITORING MARKET FOR NON-PORTABLE, BY REGION, 2019–2027 ($MILLION)
TABLE 13.FETAL MONITORING MARKET FOR PORTABLE, BY REGION, 2019–2027 ($MILLION)
TABLE 14.FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 15.FETAL MONITORING MARKET FOR NON-INVASIVE METHOD, BY REGION, 2019–2027 ($MILLION)
TABLE 16.FETAL MONITORING MARKET FOR INVASIVE METHOD, BY REGION, 2019–2027 ($MILLION)
TABLE 17.FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 18.FETAL MONITORING MARKET FOR ANTEPARTUM FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 19.FETAL MONITORING MARKET FOR INTRAPARTUM FETAL MONITORING, BY REGION, 2019–2027 ($MILLION)
TABLE 20.FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 21.FETAL MONITORING MARKET FOR HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 22.FETAL MONITORING MARKET FOR CLINICS, BY REGION, 2019–2027 ($MILLION)
TABLE 23.FETAL MONITORING MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 24.FETAL MONITORING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 25.NORTH AMERICA FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 26.NORTH AMERICA FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 27.NORTH AMERICA FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 28.NORTH AMERICA FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 29.NORTH AMERICA FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 30.NORTH AMERICA FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 31.EUROPE FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 32.EUROPE FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 33.EUROPE FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 34.EUROPE FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 35.EUROPE FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 36.EUROPE FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 37.ASIA-PACIFIC FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 38.ASIA-PACIFIC FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 40.ASIA-PACIFIC FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 41.ASIA-PACIFIC FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 42.ASIA-PACIFIC FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 43.LAMEA FETAL MONITORING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 44.LAMEA FETAL MONITORING MARKET, BY PRODUCT, 2019–2027 ($MILLION)
TABLE 45.LAMEA FETAL MONITORING MARKET, BY PORTABILITY, 2019–2027 ($MILLION)
TABLE 46.LAMEA FETAL MONITORING MARKET, BY METHOD, 2019–2027 ($MILLION)
TABLE 47.LAMEA FETAL MONITORING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.LAMEA FETAL MONITORING MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 49.ANALOGIC: COMPANY SNAPSHOT
TABLE 50.ANALOGIC: OPERATING SEGMENTS
TABLE 51.ANALOGIC:PRODUCT PORTFOLIO
TABLE 52.CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 53.CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 54.CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 55.FUJIFILM: COMPANY SNAPSHOT
TABLE 56.FUJIFILM HOLDINGS CORPORATION: PRODUCT SEGMENTS
TABLE 57.FUJIFILM: PRODUCT PORTFOLIO
TABLE 58.GE.: COMPANY SNAPSHOT
TABLE 59.GE.: OPERATING SEGMENTS
TABLE 60.GE: PRODUCT PORTFOLIO
TABLE 61.GETINGE: COMPANY SNAPSHOT
TABLE 62.GETINGE: OPERATING SEGMENTS
TABLE 63.GETINGE: PRODUCT PORTFOLIO:
TABLE 64.PHILIPS: COMPANY SNAPSHOT
TABLE 65.PHILIPS: OPERATING SEGMENTS
TABLE 66.PHILIPS: PRODUCT PORTFOLIO
TABLE 67.NATUS: COMPANY SNAPSHOT
TABLE 68.NATUS: OPERATING SEGMENTS
TABLE 69.NATUS: PRODUCT PORTFOLIO
TABLE 70.NEOVENTA: COMPANY SNAPSHOT
TABLE 71.NEOVENTA: OPERATING SEGMENTS
TABLE 72.NEOVENTA: PRODUCT PORTFOLIO
TABLE 73.OSI: COMPANY SNAPSHOT
TABLE 74.OSI: OPERATING SEGMENTS
TABLE 75.OSI: PRODUCT PORTFOLIO
TABLE 76.SIEMENS: COMPANY SNAPSHOT
TABLE 77.SIEMENS: OPERATING SEGMENTS
TABLE 78.SIEMENS: PRODUCT PORTFOLIO
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
